Seeking Alpha

More on Intuitive Surgical (ISRG): Q2 easily beats estimates across the board on a 26% jump in...

More on Intuitive Surgical (ISRG): Q2 easily beats estimates across the board on a 26% jump in total revenue, driven by continued adoption of its da Vinci surgery procedures and higher da Vinci Surgical System sales. Instruments and accessories revenue +30% Y/Y. Procedure growth +26%, boosted by higher domestic gynecologic and general surgery procedures and international urologic procedures. Despite the better numbers, the shares are currently trading -1% AH.
Comments (1)
  • ricpark
    , contributor
    Comments (2) | Send Message
     
    I love this company. Practically a monopoly and the fat premiums for the out of the money stock options for this stock make it a great hold. The volatility actually helps to make the options worth trading around the core holding. Let it drop as the puts become worth selling while the calls become worthless so you buy them back. Fun!
    19 Jul 2012, 04:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)